· The best-selling real-time CGM in the world¹ is now more powerful and easier to use with a small, all-in-one wearable and completely redesigned mobile app
· New system has the fastest sensor warmup on the market,* with no fingersticks† or scanning required
· Dexcom G7 builds on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range²,³
EDINBURGH, Scotland & SAN DIEGO, March 15 (Bernama-BUSINESS WIRE) — DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today it has secured CE Mark (Conformité Européenne) for the Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with diabetes in Europe age two years and older, including pregnant women.
- OPEC+ To Raise Oil Output In December
- Hamas Handed Over Another Israeli Hostage’s Body To Red Cross
- Expo On China’s High-End Printing Technologies Held In Dubai
- Iraq Limits Agricultural Plan Due To Drought
- Yemen’s Houthis Declare General Mobilisation Amid Fears Of Possible Israeli Attack
- Indian Security Forces Killed Four Extremists In Manipur State
- U.S. Gov’t Shutdown Set To Break Record As Senate Again Fails To Pass Funding Bill
- Iraqi PM Says “National Consensus” Reached To Bring Weapons Under State Control
- Iraq, Türkiye Signed Executive Mechanism For Water Cooperation Agreement
- Over 127 Million Voters Registered For Bangladesh’s 13th General Election